Escalera 2020.
| Study characteristics | ||
| Notes |
English title Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID‐19) in Bolivia: an analysis of the first 107 confirmed cases Study setting Start of study recruitment (MM/YYYY) 03/2020 End of study recruitment (MM/YYYY) 03/2020 Study design retrospective cohort Study centre(s) multiple centres/clinics/areas within a country Number of centres/clinics/areas unspecified Study setting outpatient and inpatient Number of participants recruited 107 Sampling method consecutive participants Participants Female participants (absolute number), 52 Age measure, value median (standard deviation), 43.9 (17.6) Inclusion criteria unspecified Exclusion criteria unspecified Smoking NR Diabetes (absolute number), 5 Hypertension (absolute number), 10 Cardiovascular diseases (absolute number), 2 Please indicate if additional information is available CHF Asthma (unspecified) Chronic obstructive pulmonary disease (unspecified) Other pulmonary diseases (unspecified) Please indicate if additional information is available NR Immunosuppression (unspecified), Please indicate if additional information is available NR Chronic kidney disease (unspecified) Cancer (unspecified) Steroid administration (unspecified) Supplemental oxygen (unspecified) Differential values for various oxygenation methods (if indicated) NR Other treatment unspecified Dose if applicable NR Duration if applicable NR Percentage received this treatment NR Prognostic factor(s) Study’s definition for obesity unspecified The time when obesity has been measured unspecified Main variable used for determination of obesity other (please specify) Threshold used for definition of obesity unspecified Measure of frequency absolute number Frequency value 6 How many eligible outcomes reported? 1 How many eligible outcomes reported? 1 Outcome(s) mortality Outcome (prognostic factor) mortality (obesity) Outcome mortality Prognostic factor (category): obesity Follow‐up Number of patients followed completely for this outcome 107 Number of obese patients followed completely for this outcome 6 Number of non‐obese patients followed completely for this outcome 101 Univariable (unadjusted) analysis for obesity Effect measure for obesity odds ratio Effect measure value (95% CI) 12.125 (1.69, 86.948) Multivariable (adjusted) analysis for obesity Modelling method other (please specify) The set of prognostic factors used for adjustment unclear Effect measure for obesity odds ratio Effect measure value (95% CI) unspecified |
|
| Item | Authors' judgement | Support for judgement |
| Study Participation | No | Appendix 3 |
| Study Attrition Mortality | Yes | Appendix 3 |
| Prognostic Factor Measurement | No | Appendix 3 |
| Outcome Measurement Mortality | Yes | Appendix 3 |
| Confounding Bias Mortality | No | Appendix 3 |
| Statistical Analysis Bias | No | Appendix 3 |